A clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images.
about
Tumour necrosis factor-mediated macrophage activation in the target organ is critical for clinical manifestation of uveitisThe role of lipoprotein-associated phospholipase A2 in a murine model of experimental autoimmune uveoretinitisAssessment and in vivo scoring of murine experimental autoimmune uveoretinitis using optical coherence tomographyIn vivo multi-modal imaging of experimental autoimmune uveoretinitis in transgenic reporter mice reveals the dynamic nature of inflammatory changes during disease progression.Longitudinal Intravital Imaging of the Retina Reveals Long-term Dynamics of Immune Infiltration and Its Effects on the Glial Network in Experimental Autoimmune Uveoretinitis, without Evident Signs of Neuronal Dysfunction in the Ganglion Cell LayerTissue-resident exhausted effector memory CD8+ T cells accumulate in the retina during chronic experimental autoimmune uveoretinitis.Quantitative evaluation of experimental choroidal neovascularization by confocal scanning laser ophthalmoscopy: fluorescein angiogram parallels heparan sulfate proteoglycan expression.Loss of synaptic connectivity, particularly in second order neurons is a key feature of diabetic retinal neuropathy in the Ins2Akita mouse.SOCS3 deletion in T lymphocytes suppresses development of chronic ocular inflammation via upregulation of CTLA-4 and expansion of regulatory T cells.Interleukin-35 induces regulatory B cells that suppress autoimmune disease.Aquaporin expression in blood-retinal barrier cells during experimental autoimmune uveitis.Age-related retinopathy in NRF2-deficient mice.MHC class II expression and potential antigen-presenting cells in the retina during experimental autoimmune uveitis.Dysregulation in retinal para-inflammation and age-related retinal degeneration in CCL2 or CCR2 deficient mice.Interleukin 27 induces the expression of complement factor H (CFH) in the retina.Age- and light-dependent development of localised retinal atrophy in CCL2(-/-)CX3CR1(GFP/GFP) mice.Use of optical coherence tomography and electroretinography to evaluate retinal pathology in a mouse model of autoimmune uveitis.Comparative analysis of induced vs. spontaneous models of autoimmune uveitis targeting the interphotoreceptor retinoid binding protein.Key role for IL-21 in experimental autoimmune uveitis.Suppressor of cytokine signaling-1 (SOCS1) inhibits lymphocyte recruitment into the retina and protects SOCS1 transgenic rats and mice from ocular inflammation.P2Y2R deficiency attenuates experimental autoimmune uveitis developmentExperimental autoimmune uveitis and other animal models of uveitis: An update.IL-33 attenuates the development of experimental autoimmune uveitis.Galectin-8 Ameliorates Murine Autoimmune Ocular Pathology and Promotes a Regulatory T Cell Response.A novel pathogenic RBP-3 peptide reveals epitope spreading in persistent experimental autoimmune uveoretinitis.S100B Up-Regulates Macrophage Production of IL1β and CCL22 and Influences Severity of Retinal InflammationAutoreactive memory CD4+ T lymphocytes that mediate chronic uveitis reside in the bone marrow through STAT3-dependent mechanisms.Topical administration of a suppressor of cytokine signaling-1 (SOCS1) mimetic peptide inhibits ocular inflammation and mitigates ocular pathology during mouse uveitis.Dual Function of the IRF8 Transcription Factor in Autoimmune Uveitis: Loss of IRF8 in T Cells Exacerbates Uveitis, Whereas Irf8 Deletion in the Retina Confers ProtectionThe Microbiota Determines Susceptibility to Experimental Autoimmune UveoretinitisWnt signaling in age-related macular degeneration: human macular tissue and mouse model.Sustained intraocular VEGF neutralization results in retinal neurodegeneration in the Ins2(Akita) diabetic mouseBlau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice.Mincle Activation and the Syk/Card9 Signaling Axis Are Central to the Development of Autoimmune Disease of the Eye.Functional macrophage heterogeneity in a mouse model of autoimmune central nervous system pathology.Role of the retinal vascular endothelial cell in ocular diseaseSTAT3 activates miR-155 in Th17 cells and acts in concert to promote experimental autoimmune uveitis.Imaging Retinal Vascular Changes in the Mouse Model of Oxygen-Induced Retinopathy.Therapeutic dosing of fingolimod (FTY720) prevents cell infiltration, rapidly suppresses ocular inflammation, and maintains the blood-ocular barrier.ITE, a novel endogenous nontoxic aryl hydrocarbon receptor ligand, efficiently suppresses EAU and T-cell-mediated immunity.
P2860
Q24633598-CDD42B12-CE84-4735-A808-4974781AEA61Q27310393-8777303D-E0B4-4217-A41A-1293698DDB16Q27321413-BEF8A432-BBDD-4934-8B15-77239FF1CD39Q30620955-678D20FF-6850-41B6-834C-146CF23DDD74Q30832864-87E6C147-E071-40D2-B752-BCF51797A5D5Q33563989-D9F9ADDD-4FB6-4B57-95AD-9E6D56CA3B75Q33577041-D398E8B3-3FF5-4503-AF25-3194108A1192Q33645320-C63ED78D-B3C9-4B4D-9081-649EB78E6675Q33697768-4432E70E-2A27-4512-AEAD-E7AB8D7D9ADDQ33721777-BD4F231F-BFCC-4940-891A-4519A0C46578Q33774524-1630EB0D-ECE2-4F8C-A244-EF1C7F5BB63AQ33894963-510098AC-4949-4173-8F11-F32FB90DFF77Q33916808-CE670BF0-103C-4998-A461-456BE6AF4A66Q33995590-37589EB4-6B12-4945-B0FF-60282A07FEFEQ34430102-33275F13-611E-46E0-A515-CB55F45A894EQ34700246-FF2F8976-55BD-4A05-AC10-354A07924AB0Q34731124-9CEED980-2299-44D9-ACA1-9478B1C24250Q34981390-FA1F277B-5E92-4A9A-BA10-FCBD711FC9E5Q35035122-97AEAC5C-BFB6-4190-B877-301DA49585CFQ35221160-72576CEB-7F32-4275-AB9B-3C7EF7A6BEA8Q35563346-67787280-F8C1-4D61-B43A-96544FAB73C1Q35663102-6A4CBA49-2284-4F4B-9390-244D1114B518Q35665373-56D5C503-8FF7-4ED2-949C-2D806D3F2E7CQ35678838-307E3512-3FE8-4030-9D35-90B3D7C41463Q35685588-D67AA094-E927-41BA-8467-4A8F0B48AACFQ35708432-70AEC9CF-1090-4FFD-A659-8B5602AA1C3AQ35831317-2677EC12-3C44-4F01-A1F1-50C6AA974283Q35930484-D8BD818E-7260-4893-95CC-7FEA207E4484Q35931594-93E36A7D-68BE-47F3-9B1A-61D2552377AFQ36050092-E21467D6-6C8A-473E-83FA-54C9E3D99559Q36171917-14DB50D3-1387-4F55-9356-0792F0E97DBEQ36376302-70870C09-DC79-44AB-BF52-2C8D6CE12F96Q36490486-02154B06-469F-4617-9176-34BAFCB34B91Q36706079-3E268B3B-66E3-4184-9BFF-B154CFE825EEQ36765022-ADDED67D-3379-4F77-A444-BCA3BF3ADFD4Q36919959-2463D7E2-E4D5-4A67-9AF1-503BDA5549ABQ36922249-CB0BCD12-8B44-462B-9654-62F389EE3DC2Q37149366-78F7390A-7CA0-4348-90D2-7D55A03E1BB7Q37229011-6503F602-9702-46B2-83E7-3EEB386F9995Q37308455-E1523B8D-5010-4CFD-90C8-89544B24394B
P2860
A clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
A clinical grading system for ...... s using digital fundus images.
@en
A clinical grading system for ...... s using digital fundus images.
@nl
type
label
A clinical grading system for ...... s using digital fundus images.
@en
A clinical grading system for ...... s using digital fundus images.
@nl
prefLabel
A clinical grading system for ...... s using digital fundus images.
@en
A clinical grading system for ...... s using digital fundus images.
@nl
P2093
P1476
A clinical grading system for ...... s using digital fundus images.
@en
P2093
Delyth M Reid
John V Forrester
Philippe Koch
P304
P356
10.1016/J.EXER.2008.06.012
P577
2008-06-26T00:00:00Z